Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,287 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02478957 | Treatment of Indolent Systemic Mastocytosis With PA101 | completed | Phase 2 | 41 | Patara PharmaINDUSTRY | 5 | Sep 29, 2016 | clinicaltrials |
| NCT01006980 | A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3) | completed | Phase 3 | 675 | Hoffmann-La RocheINDUSTRY | 12 | Sep 28, 2016 | clinicaltrials |
| NCT01599039 |
| Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema |
| completed |
| — |
| 80 |
| Nij Smellinghe HosptialOTHER |
| 1 |
| Sep 27, 2016 |
| clinicaltrials |
| NCT02033551 | A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors | completed | Phase 1 | 47 | AbbVieINDUSTRY | 3 | Sep 27, 2016 | clinicaltrials |
| NCT02828709 | Safety and Feasibility of IRE for SRMs | unknown | Phase 2 | 20 | Dr. Prof. M.P. Laguna PesOTHER | 1 | Sep 27, 2016 | clinicaltrials |
| NCT00056407 | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk(REDUCE) | completed | Phase 3 | 8,231 | GlaxoSmithKlineINDUSTRY | 42 | Sep 23, 2016 | clinicaltrials |
| NCT00094497 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | completed | Phase 3 | 304 | Collaborative Group for Adrenocortical Carcinoma TreatmentOTHER | 8 | Sep 21, 2016 | clinicaltrials |
| NCT02320734 | Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy(DEPTH) | completed | Phase 4 | 66 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT01046266 | A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 62 | Hoffmann-La RocheINDUSTRY | 5 | Sep 14, 2016 | clinicaltrials |
| NCT01252589 | Patient Reported Outcomes in Chronic Myeloid Leukemia | completed | — | 480 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 10 | Sep 14, 2016 | clinicaltrials |
| NCT01777776 | Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. | terminated | Phase 1 / Phase 2 | 28 | Array BioPharmaINDUSTRY | 4 | Sep 13, 2016 | clinicaltrials |
| NCT00169494 | Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 | completed | Phase 3 | 770 | GlaxoSmithKlineINDUSTRY | 6 | Sep 12, 2016 | clinicaltrials |
| NCT02077296 | The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer(CYTORECT) | completed | — | 34 | St. Antonius HospitalOTHER | 1 | Sep 9, 2016 | clinicaltrials |
| NCT01286753 | A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation | completed | Phase 2 | 51 | Hoffmann-La RocheINDUSTRY | 4 | Sep 7, 2016 | clinicaltrials |
| NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | completed | Phase 3 | 1,011 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 2, 2016 | clinicaltrials |
| NCT00021450 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | Phase 3 | 819 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 2, 2016 | clinicaltrials |
| NCT01826214 | Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia | completed | Phase 2 | 70 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 30, 2016 | clinicaltrials |
| NCT00123474 | Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 724 | Bristol-Myers SquibbINDUSTRY | 31 | Aug 25, 2016 | clinicaltrials |
| NCT01057810 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 837 | Bristol-Myers SquibbINDUSTRY | 24 | Aug 18, 2016 | clinicaltrials |
| NCT02621190 | Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs(CARVE) | withdrawn | Phase 2 | 0 | Erasmus Medical CenterOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT02861872 | Intra-peritoneal Chemotherapy in Ovarian Cancer | unknown | — | 15 | Radboud University Medical CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02850783 | SLN in Colon Cancer Using a Multimodal Tracer | completed | Phase 2 / Phase 3 | 10 | VU University of AmsterdamOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01830075 | The Life InSight Application Study (LISA)(LISA) | completed | N/A | 153 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 27, 2016 | clinicaltrials |
| NCT00656136 | BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1) | completed | Phase 3 | 585 | Boehringer IngelheimINDUSTRY | 15 | Jul 26, 2016 | clinicaltrials |
| NCT00519285 | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer(VENICE) | completed | Phase 3 | 1,224 | SanofiINDUSTRY | 31 | Jul 22, 2016 | clinicaltrials |
| NCT02832102 | Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)(BD2Decide) | unknown | — | 1,450 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | terminated | Phase 2 | 97 | Novartis PharmaceuticalsINDUSTRY | 15 | Jul 11, 2016 | clinicaltrials |
| NCT01034163 | A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)(PATH) | completed | Phase 3 | 41 | Novartis PharmaceuticalsINDUSTRY | 14 | Jul 7, 2016 | clinicaltrials |
| NCT01481441 | Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer(AMC_2011_190) | terminated | N/A | 208 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01798485 | A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC(Galaxy 2) | terminated | Phase 3 | 696 | Synta Pharmaceuticals Corp.INDUSTRY | 20 | Jul 1, 2016 | clinicaltrials |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer(PROCLAIM) | completed | Phase 3 | 598 | Eli Lilly and CompanyINDUSTRY | 19 | Jun 28, 2016 | clinicaltrials |
| NCT01788566 | A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer | completed | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 7 | Jun 27, 2016 | clinicaltrials |
| NCT00738530 | A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | completed | Phase 3 | 649 | Hoffmann-La RocheINDUSTRY | 18 | Jun 23, 2016 | clinicaltrials |
| NCT00785785 | A Study of Nilotinib Versus Imatinib in GIST Patients(ENESTg1) | completed | Phase 3 | 644 | Novartis PharmaceuticalsINDUSTRY | 35 | Jun 16, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT00327171 | Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer | completed | Phase 2 | 218 | SanofiINDUSTRY | 11 | Jun 7, 2016 | clinicaltrials |
| NCT00259064 | Iressa v BSC (Best Supportive Care) in First Line NSCLC(INSTEP) | completed | Phase 2 / Phase 3 | 216 | AstraZenecaINDUSTRY | 5 | Jun 2, 2016 | clinicaltrials |
| NCT02109549 | Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.(Metformin) | completed | — | 70 | Maastricht Radiation OncologyOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT01895946 | Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability(OAK) | completed | Phase 1 | 33 | AstraZenecaINDUSTRY | 2 | May 25, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT01978756 | Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic. | completed | — | 387 | Maastricht Radiation OncologyOTHER | 1 | May 24, 2016 | clinicaltrials |
| NCT00088803 | DNA Variations in the Gene in Young Patients With Wilms' Tumor | completed | — | 471 | Children's Oncology GroupNETWORK | 7 | May 19, 2016 | clinicaltrials |
| NCT02029352 | Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | completed | Phase 2 / Phase 3 | 42 | Maastricht University Medical CenterOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT02619916 | MBCT and CBT for Depression in Patients After Cancer: a Randomized Controlled Trial | unknown | N/A | 192 | University Medical Center GroningenOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT01705847 | A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies | completed | Phase 1 | 39 | Gilead SciencesINDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT00905710 | Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome(ChromoLynch) | completed | N/A | 240 | University Medical Center GroningenOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00625664 | Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer(CILAB) | completed | Phase 3 | 337 | SanofiINDUSTRY | 19 | May 5, 2016 | clinicaltrials |
| NCT02285413 | Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients | completed | Phase 2 | 54 | Radboud University Medical CenterOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT01658436 | BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. | completed | Phase 2 | 31 | Novartis PharmaceuticalsINDUSTRY | 9 | May 2, 2016 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials